If you click a social network icon and are not a looksneat user, you will be registered and you agree to looksneat's terms of service and privacy policy.Sign Up
Share FDA Approves, Leqembi, New Treatment for Early Alzheimer’s
The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other available treatments.
Request a feature